Tenet Beats Q2 Earnings on Strong Patient Volumes, Hikes '25 EPS View

Key Takeaways THC's Q2 adjusted EPS of $4.02 beat estimates by 41.6% and rose 74% year over year. Improved acuity, payer mix and cost control boosted Q2 revenues, EBITDA and margins across segments. THC raised 2025 adjusted EPS guidance to $15.55-$16.21 and hiked revenue and EBITDA projections.Tenet Healthcare Corporation (THC) reported second-quarter 2025 adjusted earnings per share (EPS) of $4.02, which surpassed the Zacks Consensus Estimate by 41.6%. The bottom line soared 74% year over year. Net opera ...